transcription-profiling-of-mouse-spleen-after-immu09celllipidlipopolysaccharidemouseFalseE-GEOD-77688816Transcription profiling of mouse spleen after immunized using LPS vs MPL as adjuvant.transcription-profiling-of-mouse-stratified-epithe08cancercellepidermishairhair folliclemelanomaskinskin cancersquamoussquamous cellmouseFalseE-GEOD-91448836Transcription profiling of mouse stratified epithelial spontaneous SCC induced by the somatic inactivation of Rb1 and Trp53 tumor suppressorstranscription-profiling-of-mouse-testicular-respon018cellhormonelipidliquidsertoli celltestismouseFalseE-GEOD-89248831Transcription profiling of mouse testicular response to recombinant follicle stimulating hormone (rFSH) in hypogonadal malestranscription-profiling-of-mouse-xxsry-males04bodycellexternalexternal genitaliagenomeinternalsertoli cellspermatidtestismouseFalseE-GEOD-53198739Transcription profiling of mouse XX/Sry malestranscription-profiling-of-transgenic-mice-l60-l8409basalbonecancercellhairproteinskinmouseFalseE-GEOD-90548833Transcription profiling of transgenic mice L60, L84 and LA overexpressiong Akt vs controls (LC)transgenic-e-myc-mouse-lymphoma-expression-data-3144cellliquidlymphomamouseFalseE-GEOD-407588648Transgenic Eµ-myc mouse lymphoma expression data for test dataset [Mouse430A_2]18f-fluorodeoxy-glucose-positron-emission-tomograp011astrocytomabreastbreast cancercancercelldiseasegenomeglucoselinehumanFalseE-GEOD-21217962818F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.267b1-pc3m-lncap-methylation-profile-vs-mrna-expre02cancercellprostateprostate cancerhumanFalseE-GEOD-9519629267B1, PC3M, LNCaP Methylation Profile vs. mRNA Expression Levelaberrant-expressed-genes-in-aml249acute myeloid leukemiacellleukemiamyeloid leukemiatestishumanFalseE-GEOD-373071248Aberrant expressed genes in AMLa-clinically-relevant-gene-signature-in-triple-neg067basalbreastbreast cancercancercelldiseaselinemedianstromahumanFalseE-GEOD-3151910008A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer